openPR Logo
Press release

In Vitro Diagnostics (IVD) and Laboratory Developed Tests for Autoimmune Diseases Market - Key Trends 2025 | Becton, Dickinson and Company

12-18-2018 12:45 PM CET | Health & Medicine

Press release from: TMR Research

/ PR Agency: TMR Research
In Vitro Diagnostics (IVD) and Laboratory Developed Tests

In Vitro Diagnostics (IVD) and Laboratory Developed Tests for Autoimmune Diseases Market: Snapshot

In vitro diagnostics and laboratory developed tests for autoimmune diseases are a key part of the global healthcare sector and are likely to account for a significant share in the same in the coming years due to the rising investment in the healthcare sector from various channels. In vitro diagnostics refers to testing performed on human tissues such as blood, urine, and other tissues in order to diagnose various diseases. The growing threat of autoimmune diseases, due to the rising prevalence of unhealthy lifestyles, is likely to remain a steady driver for the global in vitro diagnostics and laboratory developed tests for autoimmune diseases market in the coming years.

Request Sample Copy of the Report @
www.tmrresearch.com/sample/sample?flag=B&rep_id=1268

By technology, the global in vitro diagnostics and laboratory developed tests for autoimmune diseases market is segmented into clinical chemistry, molecular diagnostics, clinical microbiology, immunochemistry or immunoassay, coagulation and hemostasis, hematology, and others. The molecular diagnostics segment is likely to remain a leading contender in the global in vitro diagnostics and laboratory developed tests for autoimmune diseases market in the coming years due to the increasing attention being paid to development of genetic therapeutics in the global healthcare sector.

The growing research in human genomics is likely to play a key role in the development of the global in vitro diagnostics and laboratory developed tests for autoimmune diseases market in the coming years. Genetic components play a role in the causation of autoimmune diseases, making the development of genetic research important for the in vitro diagnostics and laboratory developed tests market.

Global In Vitro Diagnostics (IVD) and Laboratory Developed Tests for Autoimmune Diseases Market: Overview

IVDs are medical equipment that are used to test human samples of blood, urine, and tissue, and help in detecting infections, diagnosing a medical condition, and to prevent the disease. As the healthcare industry touches new peaks in the coming years, gaining from the prevalence of several chronic diseases and aging population, the demand for in vitro diagnostics as well as other laboratory developed tests (LDT) are expected to expand at a healthy growth rate during the forecast period of 2017 to 2025.

Request TOC of the Report @
www.tmrresearch.com/sample/sample?flag=T&rep_id=1268

This report on global IVD and LTD for autoimmune diseases studies all the macro and micro factors that are expected to impact the demand over the course of next few years and evaluates their implications. The report also estimates the revenue available in the global market and forecasts the future scenario. The report contains a dedicated section on company profiles, wherein a number of leading players in the industry have been analyzed for their market share, financial performance, product benchmarking, and recent strategic initiatives. The report aims to serve as an informational guide to IVD product manufacturers, original equipment manufacturers, hospitals and clinics, and research institutes.

By product and services, the global in vitro diagnostics and laboratory developed tests for autoimmune diseases market can be segmented into reagents and kits, instruments, services, and data management software. In terms of technology, the market can be bifurcated into clinical chemistry, immunochemistry or immunoassay, hematology, coagulation and hemostasis, clinical microbiology, molecular diagnostics, and other technologies. The segment of clinical chemistry can be further sub-segmented into basic metabolic panel, electrolyte panel, liver panel, lipid profile, renal profile, thyroid function panel, and specialty chemical tests. The technology segment of molecular diagnostics can also be sub-bifurcated into polymerase chain reaction, isothermal nucleic acid amplification technology (INAAT), microarrays, hybridization, DNA sequencing and next-generation sequencing, and other technologies. By application, the global market for IVD and LTD can be categorized into diabetes, infectious diseases, oncology or cancer, cardiology, nephrology, autoimmune diseases, drug testing and HIV or Aids. Hospitals, laboratories, point-of-case testing, academic institutes, and patient self-testing can be the segments of the market in terms of end user. Geographically, the report studies the growth opportunities in regions such as North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa.

Global In Vitro Diagnostics and Laboratory Developed Tests for Autoimmune Diseases Market: Trends and Opportunities

According to the report, some of the factors that are favoring the market expansion are: growing prevalence of autoimmune diseases, increasing demand for personalized medicine, and technological advancements in the field which has considerably increased the efficiency and accuracy of these diagnostic devices. However, low research budget for autoimmune diseases is expected to hinder the growth rate to a certain extent during the forecast period.

In terms of products and services, the segment of reagents and kits currently has the maximum demand, which can be attributed to the growing number of IVD tests now accessible to a wide range of reagents. Application-wise, infectious diseases are the most in-demand segment, although oncology or cancer segment is anticipated to expand at the most prominent rate during the forecast period.

Read Comprehensive Overview of Report @
www.tmrresearch.com/in-vitro-diagnostics-laboratory-devel...

Global In Vitro Diagnostics and Laboratory Developed Tests for Autoimmune Diseases Market: Regional Outlook

North America is the most lucrative regional market by a country mile, followed by Europe. This is a reflection of easy accessibility to technologically advanced products and robust healthcare infrastructure in these two regions. However, Asia Pacific, which homes nearly half of the world’s population, is expected to increase the demand exponentially in coming years, especially from emerging economies such as India, China, South Korea, Japan, and Australia.

Companies mentioned in the research report

Some of the leading companies in the global IVD and LDT market are Qiagen N.V., Roche Diagnostics, Becton, Dickinson and Company, Abbott Laboratories, Siemens Healthineers, Danaher Corporation, Bio-Rad Laboratories, Inc., bioMérieux, Johnson and Johnson, Thermo Fisher Scientific Inc., Ortho-Clinical Diagnostics, Inc., and Diasorin S.P.A.

About TMR Research
TMR Research is a premier provider of customized market research and consulting services to business entities keen on succeeding in today’s supercharged economic climate. Armed with an experienced, dedicated, and dynamic team of analysts, we are redefining the way our clients’ conduct business by providing them with authoritative and trusted research studies in tune with the latest methodologies and market trends. Our savvy custom-built reports span a gamut of industries such as pharmaceuticals, chemicals and metals, food and beverages, and technology and media, among others. With actionable insights uncovered through in-depth research of the market, we try to bring about game-changing success for our clients.

Contact:
TMR Research,
3739 Balboa St # 1097,
San Francisco, CA 94121
United States
Tel: +1-415-520-1050
Email: sales@tmrresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release In Vitro Diagnostics (IVD) and Laboratory Developed Tests for Autoimmune Diseases Market - Key Trends 2025 | Becton, Dickinson and Company here

News-ID: 1447463 • Views: 438

More Releases from TMR Research

Smoothies Market Competitive landscape, Segmentation, Manufacturers and Forecast …
Global Smoothies Market: Overview A smoothie is a thick drink made with raw fruit or vegetables mixed. A smoothie that is rich in vitamins, fibers and other nutrients is also like a healthy smoothie. Healthy smoothies are generally obtained from seeds, plants and fruits. Smoothies are mainly produced from fruits and vegetables so that the nutrients and vitamins are vital. In order to clean up and detox the body, a correct
Saccharin Market-Outlook On Emerging Application, Latest Trends & Potential Grow …
Global Saccharin Market: Introduction Saccharin, also called benzoic sulfimide (C7H5NO3S), is an artificial sweetener that is nearly 300 times sweeter compared to stable sugar. Saccharin means “overly sweet’. It is developed from oxidation of phthalic anhydride or o-toluene sulfonamide. It is available widely in the forms of crystalline powder or white crystals. These are insoluble in water, however, blend well with other sweeteners to cover up for the drawbacks. As saccharin
Textured Soy Protein Market Top Companies Statistics Analysis, Trends, Challenge …
Global Textured Soy Protein Market: An Overview Soy protein are the protein derived from soya bean and the defatted soy protein is commonly known as soy protein. The texture soy protein market is anticipated to rise on the back of its inexpensive nature and rapidly growing health-conscious population across the globe. An upcoming report on the texture soy protein market by Transparency Market Research is expected to offer an in depth analysis
Food Inclusions Market 2020 Research Report, Emerging Trends and Competitive Ana …
Global Food Inclusions Market: An Overview The food inclusions market is likely to garner a significant growth during the forecast period. This is mainly due to ability of food inclusions to improve functional properties of food. Apart from this, ability of the food inclusions to meet taste trends and offer several new flavor profiles are likely to offer new avenues for growth to the food inclusions market. Get Brochure of the Report

All 5 Releases


More Releases for IVD

Asia IVD Market
According to a new report published by Allied Market Research, the Asia Pacific In-vitro diagnostics market was valued at $12.9 billion in 2015, and is expected to reach $19.0 billion registering a CAGR of 5.6% during 2016 to 2022. The report offers a detailed analysis of the key segments, top investment pockets, changing dynamics, market size & estimations, and competitive scenario. Download Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/1256 The Asia-Pacific IVD market is
LAMEA IVD Market | Business Development Strategies
LAMEA IVD market size was valued at $7,413 million in 2016, and is projected to reach at $10,316 million by 2023, growing at a CAGR of 4.7% from 2017 to 2023. The immunodiagnostics segment accounted for more than two-ninths share of the total market in 2016. Request Sample Report at: https://www.alliedmarketresearch.com/request-sample/4137 In vitro diagnostics (IVD) are medical devices and reagents used for examination of the body samples such as blood, tissue, and
Global IVD Products Market Research Report
This report studies the global IVD Products market status and forecast, categorizes the global IVD Products market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Abbott Laboratories Danaher Corporation Johnson and Johnson Roche Diagnostics Siemens Healthcare BD Biomerieux Bio-Rad Laboratories Ortho Clinical
Europe IVD Market to Witness $19,124 Million Value by 2023
According to a new report published by Allied Market Research, titled, Europe IVD Market by Product Type, Techniques, Application, and End Users: Global Opportunity Analysis and Industry Forecast, 2017-2023, Europe IVD market was valued at $19,124 million in 2016, and is projected to reach at $26,623 million by 2023, growing at a CAGR of 4.7% from 2017 to 2023. In vitro diagnostic tests are performed using biological samples to detect the
Global IVD Reagents Market Applications & Strategies, 2022
Qyresearchreports include new market research report "Global IVD Reagents Market Research Report 2017" to its huge collection of research reports. The market study on the global IVD Reagents market is a professional tool that scrutinizes vital market indicators to understand the progression of the said between 2017-2022. The research report on the global IVD Reagents market studies historical and current performance, which are used to provide projections for crucial market indices.
IVD Market– Projections & Estimations, 2017–2023
Big Market Research added a report on “IVD Market By Product Type (Reagents, Instruments And Software & Services), By Technique (Immunodiagnostics, Blood Testing, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, And Other IVD Techniques), By Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, And Other Indications), And By End Users (Standalone Laboratory, Hospitals, Academic And Medical Schools, Point Of Care Testing, And Others) - Global Opportunity